2.Effect of hematopoietic stimulating factors on the expansion of megakaryocyte.
Journal of Central South University(Medical Sciences) 2006;31(2):204-207
OBJECTIVE:
To investigate the effect of hematopoietic stimulating factors on the expansion of mature megakaryocytes.
METHODS:
(2, 4, 6, 8, 10) x 10(5)/mL bone marrow single nucleus cells (BMNC) were added in the culture system of colony forming unit-megkaryocyte (CFU-Meg) to find out the relationship of the cultured BMNC with the output of CFU-Meg. rmSCF + rmTPO + rmIL-3 (3HSFs) and rmSCF + rmTPO + rmIL-3 + rmIL-6 (4HSFs) or F-CM were added in the liquid culture system of megkaryocytes respectively. The number of mature megakaryocytes were counted every other day.
RESULTS:
The number of CFU-Meg increased with the increase of the cultured BMNC. The CFU-Meg productivity of 1 x 10(6) BMNC/mL culture system was more than that of 2 x 10(5) BMNC/mL culture system. 3HSFs and 4HSFs or F-CM significantly promoted the expansion of mature megakaryocytes in the liquid culture system, but the effect was different. The peak time of the number of mature megakaryocytes in 3HSFs and 4HSFs or F-CM were 7 d, 7 d and 5 d respectively.
CONCLUSION
3HSFs and 4 HSFs or F-CM had positive effect on the expansion of mature megakaryocytes. 4HSFs was better than 3HSFs and F-CM. 3HSFs was better than F-CM. The peak time of the number of mature megakaryocytes in different culture systems was different.
Animals
;
Cells, Cultured
;
Colony-Forming Units Assay
;
Female
;
Hematopoietic Cell Growth Factors
;
pharmacology
;
Interleukin-3
;
pharmacology
;
Interleukin-6
;
pharmacology
;
Macrophage Colony-Stimulating Factor
;
pharmacology
;
Male
;
Megakaryocytes
;
cytology
;
Mice
3.Effect of emodin on rat bone marrow mesenchymal stem cell proliferation and mRNA expressions of hematopoietic growth factors.
Mingchao LIU ; Jianan WEI ; Junqi BAI ; Lan GUO ; Lingling OUYANG ; Xiaohui QIU
Journal of Southern Medical University 2014;34(5):736-739
OBJECTIVETo study the effect of emodin on the proliferation, cell cycle distribution, apoptosis and expression of hematopoietic growth factors in bone marrow mesenchymal stem cells (BMSCs).
METHODSThe proliferation of rat BMSCs exposed to emodin was analyzed using MTT assay, and flow cytometry was used to detect the apoptosis and cell cycle changes of the exposed cells. Real-time quantitative PCR was used to determine the mRNA expression of the hematopoietic growth factors.
RESULTSExposure to 0.1 and 1 µg/ml emodin for 48 and 72 h significantly enhanced the proliferation of BMSCs (P<0.01). The cells exposed to 0.1 µg/ml emodin showed significantly increased percentage of cells in G2/M phase (P<0.05), and 1 µg/ml emodin exposure caused increased cells in S phase (P<0.01) and decreased cells in G1/G0 phase (P<0.05). Emodin exposure for 48 h resulted in significantly decreased cell apoptosis (P<0.05). BMSCs treated with 0.1 µg/ml emodin showed a significant increase in the expression of thrombopoietin mRNA (P<0.05).
CONCLUSIONEmodin can promote the proliferation of BMSCs in vitro possibly by regulating the cell cycle distribution, cell apoptosis and thrombopoietin expression.
Animals ; Apoptosis ; Cell Cycle ; Cell Proliferation ; drug effects ; Emodin ; pharmacology ; Hematopoietic Cell Growth Factors ; metabolism ; Mesenchymal Stromal Cells ; cytology ; drug effects ; RNA, Messenger ; Rats
4.BMP-4 and VEGF promote development of hematopoietic stem cells during the embryoid body formation from embryonic stem cells.
Hui-Qin CHEN ; Xu-Chao ZHANG ; Shao-Liang HUANG ; Yun CAI ; Bei-Yan WU ; Dun-Hua ZHOU ; Ke HUANG
Journal of Experimental Hematology 2008;16(4):855-858
The objective of this study was to explore the effects of BMP-4 and VEGF on the development of primary hematopoietic stem cells during the differentiation of embryonic stem cells (ESCs) into embryoid body (EB). Murine E14 ESCs were seeded into semisolid methylcellulose-based medium for EB formation. According to added or not cytokines, experiments were divided into: (1) group of spontaneous differentiation without cytokine as control; (2) group of BMP-4 in different concentrations (0, 5, 15, 25 and 50 ng/ml); (3) group of BMP-4 combined with VEGF; (4) group of VEGF alone. EBs were collected on days 3, 6, 9, 12, 15, and the proportion of Flk-1(+) cells were assayed by flow cytometry. The results showed that in the different BMP-4 concentration groups, the proportions of Flk-1(+) cells were significantly different, and it reached the peak values in 25 ng/ml BMP-4 group as 6.51 +/- 1.02% at day 3 and 7.70 +/- 1.12% at day 6 respectively, which were statistically higher than those in control group without-BMP-4 and in 5 ng/ml BMP-4 group (p < 0.05). When BMP-4 was used in combination with VEGF, Flk-1(+) cells went to peak proportion value at day 9 as 27.53 +/- 8.14%, which was statistically higher than that in spontaneous differentiation group as 8.77 +/- 2.35% (p < 0.05) and VEGF treatment group as 11.21 +/- 2.23% (p < 0.05). It is concluded that BMP-4 in combination with VEGF can promote Flk-1(+) cells genesis during EB formation in vitro, which provides experimental evidence for researches on directed differentiation of ESCs into hematopoietic stem cells simulating the microenvironment in vivo.
Animals
;
Bone Morphogenetic Protein 4
;
pharmacology
;
Cell Differentiation
;
drug effects
;
Cells, Cultured
;
Embryonic Stem Cells
;
cytology
;
drug effects
;
Hematopoietic Stem Cells
;
cytology
;
Mice
;
Vascular Endothelial Growth Factors
;
pharmacology
5.Differential responses of CD34-positive acute myelogenous leukemic blasts to the costimulating effects of stem cell factor with GM-CSF and/or IL-3.
Yoo Hong MIN ; Seung Tae LEE ; Bong Ki LEE ; So Young CHONG ; Seok LEE ; Jee Sook HAHN ; Yun Woong KO
Yonsei Medical Journal 1995;36(1):26-36
Stem cell factor (SCF), a c-kit ligand, has a preferential effect on the proliferation of several classes of immature hematopoietic progenitor cells in combination with GM-CSF or IL-3. To analyze the costimulatory role of SCF in leukemic growth, we investigated the effect of SCF in the presence of GM-CSF and/or IL-3 on isolated CD34-positive (CD34+) leukemic blasts from 15 patients with acute myelogenous leukemia (AML). Cultures of CD34+ cells from normal bone marrow were used as controls. When the proliferation of CD34+ AML blasts in the presence of GM-CSF and/or IL-3 were evaluated in vitro for the effects of SCF, two patterns emerged. In one pattern, CD34+ AML blasts responded with a significant increase in DNA synthesis and/or colony formation when SCF was used with GM-CSF and/or IL-3 relative to the growth with SCF alone; This result is consistent with those CD34+ bone marrow cells from normal donors. Six patients (40%) were included in this category. The addition of SCF as a single factor resulted in colony formation in all six of these cases. In the other pattern, nine of the patients (60%) had CD34+ leukemic cells whose growth with SCF plus either GM-CSF, IL-3, or GM-CSF+IL-3, was not significantly different from the growth noted in the presence of SCF alone. Among them seven cases that did not form colonies in response to SCF alone, and one case showing autocrine, background growth were included. In the six cases in which the costimulating effects of SCF were documented, CD34+ c-kit+ blasts comprised 50.5 +/- 18.7% of the CD34+ leukemic blasts-higher than 21.8 +/- 19.4% of cases in which the costimulating effect of SCF was not documented. In the cases showing high c-kit antigen expression(> or = 40%), SCF had a costimulatory effect in 71% (5/7) of the patients. In conclusion, our data indicate that CD34+ leukemic blasts from a good proportion of patients with AML did not respond to the costimulating effects of SCF in the presence of GM-CSF adn/or IL-3, in contrast to those CD34+ bone marrow cells from normal donors. The possible use of SCF for acute leukemia must await further cytogenetic and molecular studies, which should clarify the preferential costimulating role of SCF in normal hematopoiesis.
Antigens, CD/*analysis
;
Antigens, CD34
;
Granulocyte-Macrophage Colony-Stimulating Factor/*pharmacology
;
Hematopoietic Cell Growth Factors/*pharmacology
;
Human
;
Interleukin-3/*pharmacology
;
Leukemia, Myelocytic, Acute/*immunology/pathology
;
Stem Cell Factor
;
Support, Non-U.S. Gov't
;
Tumor Markers, Biological
6.Comparative study of enhancing effect on mRNA expression of hematopoietic growth factors in rat bone marrow mesenchymal stem cells by ginseng polysaccharide and ginsenoside.
Jian-an WEI ; Zhi-an CHENG ; Jian-xuan WEN
Chinese Journal of Integrated Traditional and Western Medicine 2011;31(3):372-375
OBJECTIVETo study mRNA expression levels of main hematopoietic growth factors in bone marrow mesenchymal stem cells (BM-MSC), and to compare effect on mRNA expression levels treated by ginseng polysaccharide and ginsenoside.
METHODSRelative quantification real-time polymerase chain reaction (RT-PCR) was used to observe mRNA expression levels of IL4, Csf2, Kitlg, Csf1, IL6, Lif, Csf3, IL11, Epo, and IL3, etc. in rat BM-MSC treated with ginseng polysaccharide (20 microg/mL) or ginsenoside (20 microg/mL) at 12, 24, and 36 h.
RESULTSIL4 and Csf2 mRNA expressions were not detected. Relative expression of Kitlg, Csf1, IL6, Lif, Csf3, IL11, Epo and IL3 mRNA ranked in an attenuating order when compared with Gapdh mRNA. mRNA expression of Epo and IL3 was not significantly changed at any time point by treatment of ginseng polysaccharide or ginsenoside in rat BM-MSC (P > 0.05). mRNA expression of Csf1, IL6, Lif, Csf3 and IL11 were significantly enhanced at 12 and 36 h by treatment of ginseng polysaccharide (P < 0.05) and that of Csf1, IL6, Lif, Csf3, and Kitlg were significantly enhanced at 24 h in rat BM-MSC (P < 0.05). The enhanced mRNA expression was Csf3 at 12 h, Csf3, IL6 and Lif at 24 h, and Csf3, IL6, Lif, IL11, and Kitlg, respectively at 36 h by treatment of ginsenoside in rat BM-MSC.
CONCLUSIONSThe enhancement of ginseng polysaccharide was stronger than that of ginsenoside on mRNA expression of hematopoietic growth factors in the initial stage. As time went by, the enhancement of ginsenoside gradually increased and exceeded that of ginseng polysaccharide.
Animals ; Bone Marrow Cells ; drug effects ; metabolism ; Cells, Cultured ; Ginsenosides ; pharmacology ; Hematopoietic Cell Growth Factors ; metabolism ; Mesenchymal Stromal Cells ; drug effects ; metabolism ; Panax ; chemistry ; Polysaccharides ; pharmacology ; Rats ; Rats, Sprague-Dawley
7.Effects of human umbilical cord blood mesenchymal stem cells on the expansion of CD34+ cells from umbilical cord blood.
Dun-hua ZHOU ; Shao-liang HUANG ; Xu-chao ZHANG ; Jing WEI ; Yan-feng WU ; Ke HUANG ; Yang LI ; Jian-pei FANG
Chinese Journal of Pediatrics 2005;43(7):494-498
OBJECTIVEThe previous studies indicated that mesenchymal stem cells (MSCs) either from umbilical cord blood (UCB) or from bone marrow (BM) had the same biological characteristics and the function of secreting hematopoietic growth factors (HGFs). The present study aimed to understand the effects of human UCB MSCs on the expansion of CD(34)(+) cells from UCB.
METHODS1. Human UCB CD(34)(+) cells were incubated in the system containing UCB MSCs, HGFs and serum free medium. 2. The surface markers (CD(34)(+), CD(34)(+)CD(38)(-), CD(34)(+)CD(3)(+), CD(34)(+)CD(19)(+), CD(34)(+)CD(33)(+), CD(34)(+)CD(41a)(+)) on expanded UCB cells were examined by flow cytometry on the 6th and 12th days. 3. The expanded and unexpanded cells were cultured in semi-solid culturing system and checked for colony forming units of granulocyte and macrophage (CFU-GM), erythroid burst-forming unit (BFU-E), colony forming units of granulocyte- erythrocyte-megakaryocyte-macrophage (CFU-Mix) and colony forming units of high-proliferative potential (CFU-HPP).
RESULTS1. The expansion folds of CD(34)(+)CD(38)(-) cells from UCB MSCs + HGFs groups on the 6th and 12th days were 159.43 and 436.68, respectively. Interestingly, the percentage of CD(34)(+)CD(38)(-) cells declined in HGFs group after expanding for 12 days, but it rose to 9.98% in the UCB MSCs + HGFs group. 2. Colony forming capacity of expanded UCB cells showed that the folds of CFU-Mix and CFU-HPP of UCB MSCs + HGFs group increased from day 6 to day 12, but the folds decreased in the HGFs group. 3. From day 0 to day 12, CD(34)(+)CD(33)(+) cells and CD(34)(+)CD(41a)(+) cells were amplified gradually, but CD(34)(+)CD(19)(+) and CD(34)(+)CD(3)(+) cells decreased gradually, and in UCB MSCs + HGFs group this phenomenon was more significant than that in HGFs group.
CONCLUSION1. UCB MSCs containing system not only has the ability to expand the primitive HSCs but also has the ability to sustain the proliferation of HSCs. 2. UCB MSCs containing system amplified mainly myeloid and megakaryocytoid progenitor subsets. These may have clinical significance in reducing infection and hemorrhage.
Antigens, CD34 ; biosynthesis ; metabolism ; Cell Culture Techniques ; Cell Differentiation ; Cell Proliferation ; Culture Media, Conditioned ; Culture Media, Serum-Free ; Erythroid Precursor Cells ; Fetal Blood ; cytology ; Flow Cytometry ; Granulocyte-Macrophage Progenitor Cells ; Hematopoietic Cell Growth Factors ; pharmacology ; Hematopoietic Stem Cells ; metabolism ; Humans ; Infant, Newborn ; Mesenchymal Stromal Cells ; immunology ; metabolism
8.The extracellular domain of human delta-like-1 expressed and purified from CHO cells promotes expansion of hematopoietic progenitor cells.
Zhuo-Zhuang LU ; Chu-Tse WU ; Hong-Jun LIU ; Qun-Wei ZHANG ; Xiang-Xu JIA ; Li-Sheng WANG
Journal of Experimental Hematology 2003;11(3):222-226
Notch signal path plays important roles in the regulation of proliferation and differentiation of hematopoietic stem cells. An extracellular domain of human Delta-like-1 (hDll-1(ext)), one of Notch ligands, was cloned and expressed in CHO cells, and the effect of hDll-1(ext) on expansion of hematopoietic stem/progenitor cells was investigated in this study. Total RNA was isolated from human marrow mononuclear cells. hDll-1(ext) was amplified by RT-PCR and cloned to T vector, then the gene was sequenced and subcloned to pcDNA3.1/Myc-His(+)A expression vector. The constructed plasmid was transfected into CHO cells with lipofectin and the expression of secreted hDll-1(ext) in G418-resistant clones was assayed by Western blot. hDll-1(ext) high-expressed clone was cultured to collect supernatant. Fusion protein hDll-1(ext) was purified from the supernatant by immobilized metal affinity chromatography (IMAC). The results showed that expression of Notch-1 receptor was detected in cord blood-derived CD34(+) cells by RT-PCR. Human umbilical blood CD34(+) cells were cultured in serum-free medium containing SCF, IL-3, VEGF, and with or without purified hDll-1(ext) for 4 or 8 days. Effect of hDll-1(ext) on the expansion of progenitor cells was analyzed then by clonogenic assays. The number of CFU-Mix and HPP-CFC generated from the culture system containing hDll-1(ext) was 1.5 times of that from the control. In conclusion, the recombinant hDll-1(ext) promotes the expansion of primitive hematopoietic progenitors.
Animals
;
Antigens, CD34
;
immunology
;
Binding Sites
;
genetics
;
CHO Cells
;
Cell Division
;
drug effects
;
physiology
;
Colony-Forming Units Assay
;
Cricetinae
;
Endothelial Growth Factors
;
pharmacology
;
Fetal Blood
;
cytology
;
immunology
;
metabolism
;
Gene Expression
;
Genetic Vectors
;
genetics
;
Glycoproteins
;
genetics
;
pharmacology
;
physiology
;
Hematopoietic Stem Cells
;
cytology
;
drug effects
;
Humans
;
Intercellular Signaling Peptides and Proteins
;
pharmacology
;
Interleukin-3
;
pharmacology
;
Lymphokines
;
pharmacology
;
Membrane Proteins
;
genetics
;
RNA
;
genetics
;
metabolism
;
Receptor, Notch1
;
Receptors, Cell Surface
;
Recombinant Proteins
;
isolation & purification
;
pharmacology
;
Reverse Transcriptase Polymerase Chain Reaction
;
Stem Cell Factor
;
pharmacology
;
Transcription Factors
;
Transfection
;
Vascular Endothelial Growth Factor A
;
Vascular Endothelial Growth Factors
9.Expansion of erythroid progenitors and CD34+ cells by umbilical cord blood mononuclear cells.
Journal of Experimental Hematology 2005;13(3):429-433
Cord blood represents a large source of hematopoietic stem/progenitor cells. It can be induced to proliferate directly into erythroid progenitors in a appropriate ex vivo culture condition, then to generate mature red blood cells after injection into the body. The combination of Flt3 ligand, TPO, SCF and EPO is ideal for cord blood MNC to proliferate into erythroid progenitors. This study was aimed to evaluate the effect of FL, SCF and TPO on CD34(+) expansion. and to investigate influence of the cytokine combination on the proliferation of the CD34(+) cells. Mononuclear cells (MNC) were cultured in serum-free liquid culture system. Experiments were divided into 3 groups. In the group A as control no cytokines were added in the culture system; in the group B the cells cultured with SCF + FL + TPO + EPO + IGF-1; in the group C the cells were cultured with SCF + FL + TPO. EPO and IGF-1 were added at day 6. Part of the renewed MNCs and colony-forming units were counted, the proportion of CD34(+), CD34(+) CD71(+), CD71(+) GPA(+) cells was detected by FACS. The result showed that after 10 days, the the total cord blood cells increased 6.89-folds in group B and 3.06-folds in group C (P < 0.05). The CD34(+) cells increased 4.83-folds in group B and 2.47-folds in group C (P < 0.05). The colony-forming cells (CFCs) increased 4.3-folds in group B and 2.5-folds in group C (P < 0.05). Erythroid progenitors (BFU-E) and CFU-E increased 5.4-folds in group B and 3.1-folds in group C (P < 0.05). The CD34(+)CD71(+) cells increased 8.72-folds in group B and 3.37-folds in group C (P < 0.05). The CD71(+) GPA(+) cells increased 53.4-folds in group B and 30.29-folds in group C. They were different at any time point (P < 0.05). It is concluded that in the group with FL + SCF + TPO, CD34(+) cells and CFC can greatly be expanded from cord blood MNC in the serum-free culture system. In the group with FL + SCF + TPO + EPO + IGF-1, erythroid progenitors can greatly be expanded in the serum-free culture system, supplying EPO at day 0 was better than supplying at day 6. Since the largest number of colony-forming cells such as BFU-E and CFU-E were gained in the TPO + SCF + FL + EPO + IGF-1 group at day 10, the harvest time after cultivation in vitro should be selected at day 10.
Antigens, CD
;
blood
;
Antigens, CD34
;
blood
;
Cell Proliferation
;
drug effects
;
Cells, Cultured
;
Erythroid Cells
;
cytology
;
immunology
;
Fetal Blood
;
cytology
;
immunology
;
Flow Cytometry
;
Hematopoietic Stem Cells
;
cytology
;
immunology
;
Humans
;
Insulin-Like Growth Factor I
;
pharmacology
;
Leukocytes, Mononuclear
;
cytology
;
immunology
;
Receptors, Transferrin
;
blood
;
Stem Cell Factor
;
pharmacology
;
Thrombopoietin
;
pharmacology
;
Time Factors
10.Expression of survivin in cord blood CD34(+) stem/progenitor cells and its significance.
Yan-ping MA ; Ping ZOU ; Juan XIAO ; Shi-ang HUANG
Chinese Journal of Hematology 2003;24(5):238-240
OBJECTIVETo investigate the expression and significance of survivin protein and mRNA in cord blood (CB) CD(34)(+) stem/progenitor cells.
METHODSSurvivin level in CB CD(34)(+) cells was assessed by immuno-histochemistry and reverse transcription polymerase chain reaction (RT-PCR).
RESULTSSurvivin expressed in fresh CB CD(34)(+) cells, its protein level was 9.4 +/- 1.2, faint signal of the mRNA transcript band was detected. In the in vitro culture of the cells, hematopoietic growth factors could upregulate survivin expression, especially the combination of SCF, FL and Tpo. After 3 days culture, its protein level was 25.2 +/- 5.3, and mRNA transcript increased significantly. Survivin expression dropped down 24 hours after withdraw of these cytokines.
CONCLUSIONSurvivin is not a specific anti-apoptotic protein of cancer, and also expressed in normal hematopoietic stem/progenitor cells. It plays important regulating roles in the process of hematopoiesis.
Antigens, CD34 ; blood ; Cells, Cultured ; Fetal Blood ; cytology ; Hematopoietic Cell Growth Factors ; pharmacology ; Hematopoietic Stem Cells ; drug effects ; metabolism ; Humans ; Inhibitor of Apoptosis Proteins ; Microtubule-Associated Proteins ; biosynthesis ; genetics ; physiology ; Neoplasm Proteins ; biosynthesis ; genetics ; physiology ; RNA, Messenger ; genetics ; Reverse Transcriptase Polymerase Chain Reaction